Ingevity Corporation
NGVT
$40.47
$0.180.45%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.95% | -20.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.95% | -20.72% | |||
| Cost of Revenue | -10.49% | -22.83% | |||
| Gross Profit | 4.81% | -16.71% | |||
| SG&A Expenses | 9.67% | 1.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.66% | -18.88% | |||
| Operating Income | 1.62% | -27.10% | |||
| Income Before Tax | 204.55% | 106.38% | |||
| Income Tax Expenses | 180.77% | 74.59% | |||
| Earnings from Continuing Operations | 23.49% | 115.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.49% | 115.49% | |||
| EBIT | 1.62% | -27.10% | |||
| EBITDA | -9.76% | -8.62% | |||
| EPS Basic | 23.22% | 115.50% | |||
| Normalized Basic EPS | 9.53% | -41.05% | |||
| EPS Diluted | 23.40% | 115.38% | |||
| Normalized Diluted EPS | 9.60% | -41.53% | |||
| Average Basic Shares Outstanding | 0.23% | -0.12% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||